Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: Results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 trial

Journal of the American College of Cardiology

Volumn 40, Issue 1, 2002, Pages 71-77

  Morrow, David A ^a   Antman, Elliott M ^a   Sayah, Assaad ^b   Schuhwerk, Kristin C ^a   Giugliano, Robert P ^a   DeLemos, James A ^c   Waller, Michael ^d   Cohen, Sidney A ^d   Rosenberg, Donald G ^e   Cutler, Sally S ^a   McCabe, Carolyn H ^a   Walls, Ron M ^a   Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Good Samaritan Medical Center   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CENTOCOR INC   (United States)

^e UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; RETEPLASE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DRUG INDUCED DISEASE; EVALUATION; FEASIBILITY STUDY; FEMALE; FIRST AID; HEART INFARCTION; HEART MUSCLE REPERFUSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TIME; TREATMENT PLANNING;

EMERGENCY MEDICAL SERVICES; FEASIBILITY STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; RECOMBINANT PROTEINS; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0037014565     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)01936-8     Document Type: Article

References (37)

1. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction: Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)
2. Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
3. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients
4. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour
5. Prehospital use of APSAC: Results of a placebo-controlled study
6. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study
7. Prehospital thrombolysis in acute myocardial infarction
8. Prehospital-initiated vs. hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention trial
9. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial
10. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction
11. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis
12. Logistical problems in prehospital thrombolysis
13. ER TIMI-19: Testing the reality of prehospital thrombolysis
14. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy: Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators
15. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3
16. Combination reperfusion therapy with abciximab and reduced dose reteplase: Results from TIMI 14: The Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators
17. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction
18. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
19. Bolus fibrinolytic therapy in acute myocardial infarction
20. The wavefront phenomenon of ischemic cell death: Myocardial infarct size vs. duration of coronary occlusion in dogs
21. Effects of coronary artery reperfusion on myocardial infarct size and survival in conscious dogs
22. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography
23. Changes in left ventricular ejection fraction after intracoronary thrombolytic therapy: Results of the registry of the European Society of Cardiology
24. Salvage of myocardial function by coronary artery reperfusion 1, 2, and 3 hours after occlusion in conscious dogs
25. Time from symptom onset to treatment and outcomes after thrombolytic therapy: GUSTO-1 investigators
26. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: Insights from the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) trial
27. Time is myocardium and time is outcomes
28. The pre-hospital management of acute heart attacks: Recommendations of a Task Force of the European Society of Cardiology and the European Resuscitation Council
29. 31st Bethesda conference: Emergency cardiac care: Task force 2: Acute coronary syndromes: Section 2A - Prehospital issues
30. The prehospital electrocardiogram in acute myocardial infarction: Is its full potential being realized?
31. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction
32. The diagnostic impact of prehospital 12-lead electrocardiography
33. Prehospital diagnosis and treatment of acute myocardial infarction: A north-south perspective: The Cincinnati Heart Project and the Nashville Prehospital TPA trial
34. Milwaukee Prehospital Chest Pain Project - Phase I: Feasibility and accuracy of prehospital thrombolytic candidate selection
35. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
36. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial (PACT investigators: Plasminogen-activator Angioplasty Compatibility trial)